Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma, Mantle-Cell × Spinal Puncture × Clear all

Phase

Status

Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Burkitt Lymphoma 5 Meningeal Carcinomatosis 4 Lung Neoplasms 4 Breast Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Leukemia, Biphenotypic, Acute 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Mantle-Cell 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Monocytic, Acute 1 Leukemia, Hairy Cell 1 Hematopoietic and Lymphatic System Neoplasm 1 Germinoma 1 Diabetes Insipidus 1 Brain Neoplasms 1

Interventions

Rituximab 20 zanubrutinib 11 Cyclophosphamide 10 fludarabine 8 Magnetic Resonance Spectroscopy 8 Bendamustine Hydrochloride 8 pirtobrutinib 7 obinutuzumab 7 acalabrutinib 7 Specimen Handling 7 venetoclax 6 glofitamab 6 Biopsy 6 orelabrutinib 5 Cytarabine 5 fludarabine phosphate 4 Lenalidomide 4 ibrutinib 3 CT-P10 3 tafasitamab 2 loncastuximab tesirine 2 brexucabtagene autoleucel 2 Whole-Body Irradiation 2 Prednisone 2 Maintenance 2 Doxorubicin 2 Cyclosporine 2 Automobiles 2 treosulfan 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05910801 2024-11-18

V-MIND

Academic and Community Cancer Research United

Phase 2 Recruiting

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡